slotkoers
Shenzhen S.E.
00:00:00 30-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
19,75
CNY
|
-1,00%
|
|
+8,70%
|
-31,85%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
39.247
|
94.292
|
106.395
|
76.952
|
47.371
|
32.055
|
-
|
-
|
Bedrijfswaarde
1 |
35.694
|
92.214
|
107.852
|
80.810
|
51.092
|
35.189
|
34.400
|
33.720
|
K/w-verhouding
|
62,2
x
|
81,5
x
|
68,8
x
|
58,6
x
|
32,1
x
|
21,3
x
|
16,6
x
|
15,5
x
|
Dividendrendement
|
0,29%
|
0,25%
|
0,32%
|
0,44%
|
0,69%
|
1,18%
|
1,46%
|
1,22%
|
Marktkapitalisatie/omzet
|
10,4
x
|
18,4
x
|
14,3
x
|
7,5
x
|
4,11
x
|
2,54
x
|
2,1
x
|
1,97
x
|
Bedrijfswaarde/omzet
|
9,5
x
|
18
x
|
14,5
x
|
7,87
x
|
4,43
x
|
2,78
x
|
2,25
x
|
2,07
x
|
Bedrijfswaarde/EBITDA
|
37,5
x
|
54,5
x
|
45
x
|
34,8
x
|
18,7
x
|
11,5
x
|
8,96
x
|
8,44
x
|
Bedrijfswaarde/FCF
|
190
x
|
274
x
|
-3.252
x
|
-101
x
|
-493
x
|
-370
x
|
20,8
x
|
13,7
x
|
FCF Yield
|
0,53%
|
0,36%
|
-0,03%
|
-0,99%
|
-0,2%
|
-0,27%
|
4,81%
|
7,32%
|
Price to Book
|
5,27
x
|
10,8
x
|
11,1
x
|
7,83
x
|
4,12
x
|
2,55
x
|
2,24
x
|
1,98
x
|
Aantal aandelen (in duizenden)
|
1.787.372
|
1.787.372
|
1.786.898
|
1.786.601
|
1.786.732
|
1.787.394
|
-
|
-
|
Referentieprijs
2 |
22,91
|
53,51
|
62,79
|
45,33
|
28,98
|
19,75
|
19,75
|
19,75
|
Datum van publicatie
|
28-02-20
|
28-03-21
|
10-03-22
|
30-03-23
|
27-03-24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
3.757
|
5.134
|
7.444
|
10.266
|
11.538
|
12.636
|
15.257
|
16.309
|
EBITDA
1 |
951,3
|
1.692
|
2.399
|
2.321
|
2.730
|
3.059
|
3.841
|
3.996
|
Bedrijfsresultaat (EBIT)
1 |
652,2
|
874,8
|
1.914
|
1.690
|
1.722
|
1.937
|
2.529
|
2.644
|
Operationele Marge
|
17,36%
|
17,04%
|
25,72%
|
16,46%
|
14,92%
|
15,33%
|
16,58%
|
16,22%
|
Resultaat voor belastingen (EBT)
1 |
632,6
|
1.319
|
1.911
|
1.666
|
1.838
|
1.843
|
2.529
|
2.604
|
Nettowinst (verlies)
1 |
547,2
|
1.172
|
1.661
|
1.375
|
1.601
|
1.605
|
2.176
|
2.255
|
Nettomarge
|
14,56%
|
22,84%
|
22,31%
|
13,39%
|
13,88%
|
12,7%
|
14,27%
|
13,83%
|
WPA
2 |
0,3681
|
0,6569
|
0,9128
|
0,7739
|
0,9019
|
0,9285
|
1,189
|
1,270
|
Free Cash Flow
1 |
187,4
|
336
|
-33,17
|
-803,9
|
-103,7
|
-95
|
1.653
|
2.468
|
FCF-marge
|
4,99%
|
6,54%
|
-0,45%
|
-7,83%
|
-0,9%
|
-0,75%
|
10,84%
|
15,13%
|
Kasstroomconversie (ebitda)
|
19,7%
|
19,86%
|
-
|
-
|
-
|
-
|
43,04%
|
61,76%
|
Kasstroomconversie (nettowinst)
|
34,25%
|
28,66%
|
-
|
-
|
-
|
-
|
75,97%
|
109,44%
|
Dividend per aandeel
2 |
0,0667
|
0,1333
|
0,2000
|
0,2000
|
0,2000
|
0,2327
|
0,2876
|
0,2402
|
Datum van publicatie
|
28-02-20
|
28-03-21
|
10-03-22
|
30-03-23
|
27-03-24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019 S2
|
2020 S1
|
2020 S2
|
2021 S1
|
2021 Q4
|
2021 S2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2023 S2
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
2025 Q1
|
2025 Q2
|
---|
Omzet
1 |
2.121
|
2.193
|
2.940
|
3.286
|
2.142
|
4.158
|
4.635
|
-
|
2.863
|
5.632
|
2.724
|
2.916
|
5.640
|
2.920
|
2.978
|
5.898
|
2.671
|
3.196
|
5.761
|
3.316
|
3.534
|
6.820
|
3.239
|
3.379
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-
|
-
|
-
|
677,9
|
708,3
|
1.245
|
760,3
|
510,1
|
414,9
|
925
|
431,6
|
482,3
|
913,9
|
414,6
|
424,2
|
838,8
|
268,4
|
466
|
775
|
520,1
|
579,4
|
1.092
|
-
|
-
|
Operationele Marge
|
-
|
-
|
-
|
20,63%
|
33,06%
|
29,93%
|
16,4%
|
-
|
14,49%
|
16,42%
|
15,84%
|
16,54%
|
16,2%
|
14,2%
|
14,25%
|
14,22%
|
10,05%
|
14,58%
|
13,45%
|
15,68%
|
16,39%
|
16,01%
|
-
|
-
|
Resultaat voor belastingen (EBT)
1 |
-
|
-
|
-
|
-
|
708,4
|
1.245
|
-
|
464,8
|
458,9
|
-
|
426,6
|
481,9
|
908,5
|
412,4
|
516,9
|
929,4
|
-
|
497
|
765
|
485
|
613
|
1.098
|
-
|
-
|
Nettowinst (verlies)
1 |
-
|
-
|
-
|
564,8
|
621
|
1.096
|
-
|
375,7
|
413,5
|
-
|
348,3
|
437,8
|
786,1
|
352,9
|
462,1
|
815
|
-
|
420
|
635
|
415
|
553
|
968
|
-
|
-
|
Nettomarge
|
-
|
-
|
-
|
17,19%
|
28,99%
|
26,36%
|
-
|
-
|
14,44%
|
-
|
12,78%
|
15,01%
|
13,94%
|
12,09%
|
15,52%
|
13,82%
|
-
|
13,14%
|
11,02%
|
12,51%
|
15,65%
|
14,19%
|
-
|
-
|
WPA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0,2000
|
0,2598
|
-
|
-
|
-
|
-
|
-
|
0,2300
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
28-02-20
|
26-08-20
|
28-03-21
|
29-08-21
|
10-03-22
|
10-03-22
|
29-08-22
|
27-10-22
|
30-03-23
|
30-03-23
|
27-04-23
|
27-08-23
|
27-08-23
|
29-10-23
|
27-03-24
|
27-03-24
|
25-04-24
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
1.457
|
3.859
|
3.721
|
3.133
|
2.345
|
1.665
|
Nettokaspositie
1 |
3.553
|
2.077
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
0,6074
x
|
1,663
x
|
1,363
x
|
1,024
x
|
0,6104
x
|
0,4166
x
|
Free Cash Flow
1 |
187
|
336
|
-33,2
|
-804
|
-104
|
-95
|
1.653
|
2.468
|
ROE (netto-inkomsten/eigen vermogen)
|
10,9%
|
14,1%
|
17,3%
|
13,3%
|
13,9%
|
12,1%
|
13,7%
|
13,1%
|
ROA (netto-inkomsten/totale activa)
|
7,43%
|
10,7%
|
8,85%
|
-
|
6,82%
|
6,66%
|
8,26%
|
7,78%
|
Totale activa
1 |
7.368
|
10.922
|
18.767
|
-
|
23.485
|
24.106
|
26.348
|
28.998
|
Nettoactief per aandeel
2 |
4,350
|
4,960
|
5,670
|
5,790
|
7,030
|
7,760
|
8,820
|
9,950
|
Cashflow per aandeel
2 |
0,5300
|
0,9200
|
1,130
|
1,200
|
1,540
|
1,330
|
1,640
|
1,780
|
Capex
1 |
751
|
1.313
|
2.091
|
2.947
|
2.857
|
2.220
|
1.924
|
1.898
|
Capex/omzet
|
19,99%
|
25,57%
|
28,09%
|
28,7%
|
24,76%
|
17,57%
|
12,61%
|
11,64%
|
Datum van publicatie
|
28-02-20
|
28-03-21
|
10-03-22
|
30-03-23
|
27-03-24
|
-
|
-
|
-
|
Gemiddeld advies Accumuleren Laatste slotkoers
19,75
CNY Gemiddelde koersdoel
24,22
CNY Spread / Gemiddelde doel +22,65% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -31,85% | 4,43 mld. | | +0,17% | 42,19 mld. | | +10,92% | 42,24 mld. | | +44,30% | 40,15 mld. | | -6,20% | 28,31 mld. | | +5,23% | 24,63 mld. | | -24,79% | 18,2 mld. | | +26,69% | 12,01 mld. | | -3,13% | 11,76 mld. | | +6,57% | 10,4 mld. |
Biotechnologie & Medisch Onderzoek - Andere
|